TY - JOUR
T1 - Enhanced transformation of human immunocompetent cells by dibutyryl adenosine cyclic 3', 5'-monophosphate 1
AU - Gallo, Robert C.
AU - Whang-Peng, Jacqueline
PY - 1971/1/1
Y1 - 1971/1/1
N2 - Dibutyryl adenosine cyclic 3', 5'-monophosphate (10'7-10-6 M) augmented the response (transformation, DNA synthesis, and mitosis)of normal human lymphocytes to antigenic or mitogenic stimulation. Incontrast, the response of lymphocytes from patients with lymphocyticleukemia was not enhanced. Higher concentrations (10-6-10-5 M) wereinhibitory with both normal and leukemic lymphocytes.—J Nat CancerInst 47: 91-94, 1971.
AB - Dibutyryl adenosine cyclic 3', 5'-monophosphate (10'7-10-6 M) augmented the response (transformation, DNA synthesis, and mitosis)of normal human lymphocytes to antigenic or mitogenic stimulation. Incontrast, the response of lymphocytes from patients with lymphocyticleukemia was not enhanced. Higher concentrations (10-6-10-5 M) wereinhibitory with both normal and leukemic lymphocytes.—J Nat CancerInst 47: 91-94, 1971.
UR - http://www.scopus.com/inward/record.url?scp=0015094067&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0015094067&partnerID=8YFLogxK
U2 - 10.1093/jnci/47.1.91
DO - 10.1093/jnci/47.1.91
M3 - Article
C2 - 4328198
AN - SCOPUS:0015094067
VL - 47
SP - 91
EP - 94
JO - Cancer chemotherapy reports. Part 1
JF - Cancer chemotherapy reports. Part 1
SN - 0027-8874
IS - 1
ER -
